Raymond James upgraded shares of RadNet (NASDAQ:RDNT – Free Report) from an outperform rating to a strong-buy rating in a report published on Wednesday morning, Marketbeat.com reports.

The expansion plans build on previously established Nociscan sites with RadNet affiliates in both states and are driven by the increased availability of MR Spectroscopy (MRS) and enhanced remote ...

The expansion plans build on previously established Nociscan sites with RadNet (RDNT) affiliates in both states and are driven by the increased availability of MR Spectroscopy and enhanced remote ...

The expansion plans build on previously established Nociscan sites with RadNet affiliates in both states and are driven by the increased availability of MR Spectroscopy (MRS) and enhanced remote ...

Private Advisor Group LLC purchased a new stake in RadNet, Inc. (NASDAQ:RDNT – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission.

Fintel reports that on March 5, 2025, Raymond James upgraded their outlook for RadNet (NasdaqGM:RDNT) from Outperform to Strong Buy. As of March 4, 2025, the average one-year price target for ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare industry to assess business performance, and is a measure of leverage capacity ...

If you’re on the fence about investing in GeneDx Holdings Corp., RadNet or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision ...

Diagnostic imaging company RadNet (NASDAQ:RDNT) will be reporting results tomorrow after market hours. Here’s what to look for. RadNet beat analysts’ revenue expectations by 4.8% last quarter ...